Clinical Trial Update: A Study of TRS01 in Participants With Post-surgical Ocular Inflammation [Phase 1, Phase 2]

View source ↗

Summary

Phase 1/2 clinical trial of TRS01 in participants with post-surgical ocular inflammation has completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Post-surgical Ocular Inflammation

Drugs mentioned

• TRS01

Snippet

Sponsor: Tarsier Pharma | Conditions: Post Surgical Ocular Inflammation | Phase 1, Phase 2 | Status: COMPLETED | Results posted: 2021-10-14